|
1.
|
Chen J, Pan J, Zheng X, et al: Number and
location of positive nodes, postoperative radiotherapy, and
survival after esophagectomy with three-field lymph node dissection
for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol
Biol Phys. 82:475–482. 2012. View Article : Google Scholar
|
|
2.
|
Yuequan J, Shifeng C and Bing Z:
Prognostic factors and family history for survival of esophageal
squamous cell carcinoma patients after surgery. Ann Thorac Surg.
90:908–913. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Altorki N, Kent M, Ferrara C and Port J:
Three-field lymph node dissection for squamous cell and
adenocarcinoma of the esophagus. Ann Surg. 236:177–183. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Medical Research Council Oesophageal
Cancer Working Group: Surgical resection with or without
preoperative chemotherapy in oesophageal cancer: a randomized
controlled trial. Lancet. 359:1727–1733. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Blamey RW, Hornmark-Stenstam B, Ball G, et
al: ONCOPOOL - a European database for 16,944 cases of breast
cancer. Eur J Cancer. 46:56–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Morris EJ, Sandin F, Lambert PC, et al: A
population-based comparison of the survival of patients with
colorectal cancer in England, Norway and Sweden between 1996 and
2004. Gut. 60:1087–1093. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: key players in the immune system, differentiation,
tumori-genesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
He L, Thomson JM, Hemann MT, et al: A
microRNA polycistron as a potential human oncogene. Nature.
435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Calin GA, Trapasso F, Shimizu M, et al:
Familial cancer associated with a polymorphism in ARLTS1. N Engl J
Med. 352:1667–1676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Feber A, Xi L, Luketich JD, et al:
MicroRNA expression profiles of esophageal cancer. J Thorac
Cardiovasc Surg. 135:255–260. 2008. View Article : Google Scholar
|
|
18.
|
Guo Y, Chen Z, Zhang L, et al: Distinctive
microRNA profiles relating to patient survival in esophageal
squamous cell carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Hiyoshi Y, Kamohara H, Karashima R, et al:
MicroRNA-21 regulates the proliferation and invasion in esophageal
squamous cell carcinoma. Clin Cancer Res. 15:1915–1922. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kano M, Seki N, Kikkawa N, et al: miR-145,
miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in
esophageal squamous cell carcinoma. Int J Cancer. 127:2804–2814.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Tomasetto C, Regnier C, Moog-Lutz C, et
al: Identification of four novel human genes amplified and
overexpressed in breast carcinoma and localized to the q11-21.3
region of chromosome 17. Genomics. 28:367–376. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Zhao L, Wang H, Liu C, et al: Promotion of
colorectal cancer growth and metastasis by the LIM and SH3 domain
protein 1. Gut. 59:1226–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Takahashi K, Kanazawa H, Chan CT, Hosono
T, Takahara M and Sato K: A case of esophageal carcinoma metastatic
to the mandible and characterization of 2 cell lines (T.T and T.
Tn) established from the oral tumor. Jpn J Oral Maxillofac Surg.
36:67–76. 1990. View Article : Google Scholar
|
|
24.
|
Nishihira T, Kasai M, Mori S, et al:
Characteristics of 2 cell lines (TE-1 and TE-2) derived from human
squamous cell carcinoma of the esophagus. Gann. 70:575–584.
1979.PubMed/NCBI
|
|
25.
|
Yi R, Poy MN, Stoffel M and Fuchs E: A
skin microRNA promotes differentiation by repressing ‘stemness’.
Nature. 452:225–229. 2008.
|
|
26.
|
Lena AM, Shalom-Feuerstein R, Rivetti di
Val Cervo P, et al: miR-203 represses ‘stemness’ by repressing
DeltaNp63. Cell Death Differ. 15:1187–1195. 2008.
|
|
27.
|
Bueno MJ, Pérez de Castro I, Gómez de
Cedrón M, et al: Genetic and epigenetic silencing of microRNA-203
enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell.
13:496–506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Yuan Y, Zeng ZY, Liu XH, et al:
MicroRNA-203 inhibits cell proliferation by repressing ΔNp63
expression in human esophageal squamous cell carcinoma. BMC Cancer.
11:572011.
|
|
30.
|
Bo J, Yang G, Huo K, et al: microRNA-203
suppresses bladder cancer development by repressing bcl-w
expression. FEBS J. 278:786–792. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Castilla MÁ, Moreno-Bueno G, Romero-Pérez
L, et al: Micro-RNA signature of the epithelial-mesenchymal
transition in endometrial carcinosarcoma. J Pathol. 223:72–80.
2011.PubMed/NCBI
|
|
32.
|
Saini S, Majid S, Yamamura S, et al:
Regulatory role of mir-203 in prostate cancer progression and
metastasis. Clin Cancer Res. 17:5287–5298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Chen HY, Han ZB, Fan JW, et al: miR-203
expression predicts outcome after liver transplantation for
hepatocellular carcinoma in cirrhotic liver. Med Oncol. Jul
24–2011.(Epub ahead of print).
|
|
34.
|
Chew CS, Chen X, Parente JA Jr, Tarrer S,
Okamoto C and Qin HY: Lasp-1 binds to non-muscle F-actin in vitro
and is localized within multiple sites of dynamic actin assembly in
vivo. J Cell Sci. 115:4787–4799. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Lin YH, Park ZY, Lin D, et al: Regulation
of cell migration and survival by focal adhesion targeting of
Lasp-1. J Cell Biol. 165:421–432. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Chiyomaru T, Enokida H, Kawakami K, et al:
Functional role of LASP1 in cell viability and its regulation by
microRNAs in bladder cancer. Urol Oncol. 30:434–443. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Viticchiè G, Lena AM, Latina A, et al:
miR-203 controls proliferation, migration and invasive potential of
prostate cancer cell lines. Cell Cycle. 10:1121–1131.
2011.PubMed/NCBI
|
|
38.
|
Sadanandam A, Varney ML, Singh S, et al:
High gene expression of semaphorin 5A in pancreatic cancer is
associated with tumor growth, invasion and metastasis. Int J
Cancer. 127:1373–1383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Choi SY, Jang JH and Kim KR: Analysis of
differentially expressed genes in human rectal carcinoma using
suppression subtractive hybridization. Clin Exp Med. 11:219–226.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Song K, Li Q, Peng YB, et al: Silencing of
hHS6ST2 inhibits progression of pancreatic cancer through
inhibition of Notch signalling. Biochem J. 436:271–282. 2011.
View Article : Google Scholar : PubMed/NCBI
|
